Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

On Friday, former FDA Commissioner and current Pfizer board member Dr. Scott Gottlieb appeared on CNBC’s “Squawk Pod” to discuss COVID-19 and the latest variant, a sub-variant of Omicron.

When asked what Americans should know about the latest variant, Gottlieb said that there are three questions. First, “is it more contagious?”

 

Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

Trump Revokes Obama-Era Climate Rule, Marking Major Shift in Federal Authority

Trump Revokes Obama-Era Climate Rule, Marking Major Shift in…
Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

Rising Tensions With Iran Put Middle East on Edge

Escalating U.S.–Iran tensions threaten Middle East stability…
Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

Peace Agreement or Prophetic Prelude? Analyzing the Board of Peace

Is the “Board of Peace” a Prophetic Precursor to an Israeli-Palestinian…